The majority of studies have reported that FASN induces EMT in cancer cells; however, some studies have shown that FASN-induced EMT can be inhibited in breast and lung cancer cells by rewiring the metabolic state of the cells [76,77]. The gene discussed is FASN; the disease is lung cancer.